Ibuprofen and Bronchial secretion retention - a phase IV clinical study of FDA data

Summary:

Bronchial secretion retention is reported as a side effect among people who take Ibuprofen (ibuprofen), especially for people who are male, 60+ old, also take Atrovent, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Bronchial secretion retention when taking Ibuprofen. It is created by eHealthMe based on reports of 239,218 people who have side effects when taking Ibuprofen from the FDA, and is updated regularly.

What is Ibuprofen?

Ibuprofen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,270 Ibuprofen users. Check the latest studies of Ibuprofen.

What is Bronchial secretion retention?

Bronchial secretion retention is found to be associated with 276 drugs and 309 conditions by eHealthMe. Check the latest studies of Bronchial secretion retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

239,218 people reported to have side effects when taking Ibuprofen.
Among them, 35 people (0.01%) have Bronchial secretion retention.

Could Ibuprofen cause Bronchial secretion retention?

Among these 35 people:

What is the gender of people who have Bronchial secretion retention when taking Ibuprofen? *

  • female: 14.71 %
  • male: 85.29 %

What is the age of people who have Bronchial secretion retention when taking Ibuprofen? *

  • 0-1: 6.25 %
  • 2-9: 9.38 %
  • 10-19: 12.5 %
  • 20-29: 6.25 %
  • 30-39: 6.25 %
  • 40-49: 0.0 %
  • 50-59: 21.88 %
  • 60+: 37.5 %

What are other drugs people take besides Ibuprofen? *

  1. Atrovent: 16 people, 45.71%
  2. Reglan: 14 people, 40.00%
  3. Singulair: 14 people, 40.00%
  4. Motrin: 13 people, 37.14%
  5. Mucinex: 13 people, 37.14%
  6. Avodart: 13 people, 37.14%
  7. Dilaudid: 13 people, 37.14%
  8. Prozac: 13 people, 37.14%
  9. Protonix: 13 people, 37.14%
  10. Prilosec: 13 people, 37.14%

What are other side effects people have besides Bronchial secretion retention? *

  1. Dyspnea (difficult or laboured breathing): 23 people, 65.71%
  2. Weakness: 22 people, 62.86%
  3. Atelectasis (partial or complete collapse of the lung): 22 people, 62.86%
  4. Sputum Discolored: 22 people, 62.86%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 21 people, 60.00%
  6. Chest Pain: 20 people, 57.14%
  7. Pneumonia: 15 people, 42.86%
  8. Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 14 people, 40.00%
  9. General Physical Health Deterioration (weak health status): 14 people, 40.00%
  10. Sepsis (a severe blood infection that can lead to organ failure and death): 14 people, 40.00%

What are the existing conditions these people have? *

  1. Asthma: 13 people, 37.14%
  2. Multiple Myeloma (cancer of the plasma cells): 13 people, 37.14%
  3. Quit Smoking: 7 people, 20.00%
  4. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 5.71%
  5. Pseudomonas Bronchitis (bronchitis by bacterium (genus pseudomonas) of a genus that occurs in soil and detritus): 2 people, 5.71%
  6. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 5.71%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 2.86%
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 1 person, 2.86%
  9. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 2.86%
  10. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Ibuprofen and have Bronchial secretion retention?

- Check whether Bronchial secretion retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibuprofen:

Bronchial secretion retention treatments and more:

How severe was Bronchial secretion retention and when was it recovered:

Expand to all the drugs that have ingredients of ibuprofen:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ibuprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchial secretion retention:

Browse all the conditions that are associated with Bronchial secretion retention:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibuprofen) and Ibuprofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: